BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 35 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $147,873 | -54.2% | 448,101 | 0.0% | 0.03% | -56.4% |
| Q4 2022 | $322,633 | -39.9% | 448,101 | 0.0% | 0.08% | -27.1% |
| Q3 2022 | $537,000 | -13.0% | 448,101 | -14.4% | 0.11% | -5.3% |
| Q2 2022 | $617,000 | -45.4% | 523,348 | 0.0% | 0.11% | -24.2% |
| Q1 2022 | $1,131,000 | +53.0% | 523,348 | +5.4% | 0.15% | +35.5% |
| Q4 2021 | $739,000 | -49.1% | 496,756 | 0.0% | 0.11% | +7.8% |
| Q3 2021 | $1,451,000 | -12.1% | 496,756 | -0.6% | 0.10% | -23.3% |
| Q2 2021 | $1,650,000 | -12.3% | 500,000 | 0.0% | 0.13% | +111.1% |
| Q1 2021 | $1,881,000 | +6.6% | 500,000 | 0.0% | 0.06% | -19.2% |
| Q4 2020 | $1,765,000 | – | 500,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 159,500 | $563,000 | 0.11% |
| Ikarian Capital, LLC | 500,000 | $1,765,000 | 0.08% |
| Anson Funds Management LP | 99,103 | $350,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 66,558 | $235,000 | 0.04% |
| AJU IB Investment Co., Ltd. | 25,651 | $91,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 53,041 | $187,000 | 0.01% |
| SHUFRO ROSE & CO LLC | 12,941 | $46,000 | 0.00% |
| Baker Brothers Advisors | 249,123 | $879,000 | 0.00% |
| Tekla Capital Management LLC | 6,000 | $21,000 | 0.00% |
| Orion Capital Management LLC | 500 | $2,000 | 0.00% |